In addition to my day job, I'm trying to keep up with my scholarship. One thing I've been working on is a reimplementation of a popular tool (TransRate) for evaluating de novo transcriptome assemblies. See the paper here: https://t.co/QNP7ViQs4j
In addition to my day job, I'm trying to keep up with my scholarship. One thing I've been working on is a reimplementation of a popular tool (TransRate) for evaluating de novo transcriptome assemblies. See the paper here: https://t.co/QNP7ViQs4j
I assume that @NSF panels continue to be on hold, but can anyone confirm? Website says panels are on, after 2/10 and I guess it's just that the communication has not been updated yet.
As expected, a large group of states have filed suit against the NIH and its acting director to block the across-the-board decreases in indirect cost rates announced on Friday, calling the NIH's actions "unlawful".
https://t.co/iDdWCzP2oq
In response to the federal directive issued on Feb. 7, 2025 to change the Facilities and Administration rate for all existing and ongoing new @NIH research awards, UW–Madison has issued the following statement.
https://t.co/2tJLfF3sq3
Last year, $9B of the $35B that the National Institutes of Health (NIH) granted for research was used for administrative overhead, what is known as “indirect costs.” Today, NIH lowered the maximum indirect cost rate research institutions can charge the government to 15%, above what many major foundations allow and much lower than the 60%+ that some institutions charge the government today. This change will save more than $4B a year effective immediately.
One thing I have taken away from the #Election2024: What I (we) consumed on social and mainstream media was mostly false. Intentional or not, almost nothing was based on evidence or fact, rather, it was the opinion of generally misguided pundits who are gifted storytellers.